| Lysyl oxidase‐like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal‐like breast carcinomas G Moreno‐Bueno, F Salvador, A Martín, A Floristán, EP Cuevas, V Santos, ... EMBO molecular medicine 3 (9), 528-544, 2011 | 182 | 2011 |
| Lysyl oxidase‐like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression A Martin, F Salvador, G Moreno‐Bueno, A Floristán, C Ruiz‐Herguido, ... The EMBO journal 34 (8), 1090-1109, 2015 | 100 | 2015 |
| Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis K Kleffman, G Levinson, IVL Rose, LM Blumenberg, SAA Shadaloey, ... Cancer discovery 12 (5), 1314-1335, 2022 | 45 | 2022 |
| Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability PG Santamaría, A Floristán, B Fontanals-Cirera, A Vázquez-Naharro, ... Cell Death & Differentiation 25 (5), 935-950, 2018 | 44 | 2018 |
| Functional analysis of RPS27 mutations and expression in melanoma A Floristán, L Morales, D Hanniford, C Martinez, E Castellano‐Sanz, ... Pigment cell & melanoma research 33 (3), 466-479, 2020 | 16 | 2020 |
| Loxl3 promotes melanoma progression and dissemination influencing cell plasticity and survival A Vázquez-Naharro, J Bustos-Tauler, A Floristán, L Yuste, SS Oltra, ... Cancers 14 (5), 1200, 2022 | 8 | 2022 |
| Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development PG Santamaría, P Dubus, J Bustos-Tauler, A Floristán, ... International journal of molecular sciences 23 (10), 5730, 2022 | 4 | 2022 |
| Abstract LB052: Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis K Kleffman, G Levinson, IV Rose, L Blumenberg, SA Shadaloey, ... Cancer Research 82 (12_Supplement), LB052-LB052, 2022 | | 2022 |
| Lysyl oxidase-like 3 is a novel druggable target in melanoma PG Santamaría, A Floristán, J Bustos-Tauler, A Vázquez-Naharro, A Cano | | 2018 |
